Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000919574-19-003860

Director bought 29,000 shares at an average $5.02 ($145,539)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-23 Purchase : show line 1 in the form +14,100 $5.05 $71,205 18,348,385 D
2019-05-23 Purchase : show line 2 in the form +0 18,348,385 I
2019-05-24 Purchase : show line 3 in the form +11,400 $5.01 $57,114 18,359,785 D
2019-05-24 Purchase : show line 4 in the form +0 18,359,785 I
2019-05-28 Purchase : show line 5 in the form +3,500 $4.92 $17,220 18,363,285 D
2019-05-28 Purchase : show line 6 in the form +0 18,363,285 I
Open-market purchases · 29,000 sh · avg $5.02 · $145,539
Loading xslF345X03/ownership.xml…